首页|盐酸氟西汀联合戊酸雌二醇治疗围绝经期抑郁障碍患者的疗效研究

盐酸氟西汀联合戊酸雌二醇治疗围绝经期抑郁障碍患者的疗效研究

扫码查看
目的 探究盐酸氟西汀联合戊酸雌二醇治疗围绝经期抑郁障碍患者的临床效果.方法 选取2021年1月至2024年1月绍兴市第七人民医院收治的围绝经期抑郁障碍患者120例作为研究对象.采用随机数字表法将患者分为对照组和观察组,每组60例.对照组患者接受戊酸雌二醇治疗,观察组在对照组基础上联合盐酸氟西汀治疗,所有患者均接受8周连续治疗.分别于治疗4周和治疗8周时应用汉密尔顿抑郁量表(Hamilton depression scale,HAMD)比较两组患者治疗前后的抑郁严重程度;应用改良Kupperman指数(modified Kupperman index,KMI)比较两组患者治疗前后的绝经期症状严重程度;检测并比较两组患者治疗前后卵泡刺激素(follicle stimulating hormone,FSH)、黄体生成素(luteinizing hormone,LH)、雌二醇(estradiol,E2)等性激素水平的变化;采用Spearman法分析患者的抑郁严重程度与性激素水平、围绝经期症状严重程度的相关性.结果 治疗4周和8周时,观察组患者的HAMD及KMI评分均低于本组治疗前,且低于对照组(P<0.05);两组患者的FSH、LH水平低于本组治疗前,E2水平高于本组治疗前(P<0.05).Spearman相关性分析表明HAMD评分与KMI评分、FSH水平、LH水平呈正相关,与E2呈负相关.结论 与单独应用戊酸雌二醇相比,盐酸氟西汀联合戊酸雌二醇更有利于减轻围绝经期抑郁障碍患者的抑郁程度,且患者的抑郁程度与症状严重程度、性激素水平密切相关,提示该联合治疗方案对围绝经期抑郁障碍患者具有较广泛的应用价值.
Study on the efficacy of fluoxetine hydrochloride combined with estradiol valerate in the treatment of perimenopausal depression patients
Objective To explore the clinical efficacy of fluoxetine hydrochloride combined with estradiol valerate in the treatment of perimenopausal depression patients.Methods A total of 120 patients with perimenopausal depressive disorder admitted to Shaoxing 7th People's Hospital from January 2021 to January 2024 were selected as the study subjects.According to random number table method,the patients were divided into control group and observation group,60 cases in each group.The control group patients received estradiol valerate treatment,while the observation group patients additionally received fluoxetine hydrochloride.All patients were treated continuously for 8 weeks.At 4 weeks and 8 weeks of treatment,Hamilton depression scale (HAMD) was used to compare depression severity before and after treatment.Modified Kupperman index (KMI) was used to compare severity of menopausal symptoms before and after treatment.Changes in sex hormone levels,including follicle stimulating hormone (FSH),luteinizing hormone (LH),and estradiol (E2) were measured and compared before and after treatment.The correlation between depression severity and sex hormone levels and the severity of menopausal symptoms were evaluated using Spearman correlation analysis.Results At 4 weeks and 8 weeks of treatment,HAMD and KMI scores of observation group were significantly lower than before treatment,and lower than those of control group (P<0.05).The FSH and LH levels in both groups were significantly lower than before treatment,while E2 levels were significantly higher than before treatment (P<0.05).Spearman correlation analysis showed that HAMD score were positively correlated with KMI score,FSH level,and LH level,and negatively correlated with E2 level.Conclusion Compared with the use of estradiol valerate alone,the combination of fluoxetine hydrochloride and estradiol valerate is more effective in alleviating the severity of depression in patients with perimenopausal depression.Moreover,the severity of depression is closely related to the severity of symptoms and sex hormone levels,suggesting that this combined treatment regimen has broader applicability for patients with perimenopausal depression.

Fluoxetine hydrochlorideEstradiol valeratePerimenopausal depressiveHormones

张迪、陈莹、丁会、陈晶

展开 >

绍兴市第七人民医院重症精神科,浙江绍兴 312000

绍兴市第七人民医院普通精神科,浙江绍兴 312000

盐酸氟西汀 戊酸雌二醇 围绝经期抑郁障碍 激素

2024

中国现代医生
中国医学科学院

中国现代医生

影响因子:1.571
ISSN:1673-9701
年,卷(期):2024.62(30)